Volume 23, Issue 5 , Pages 614-618, October 2009
The Effect of Xenon on Isoflurane Protection Against Experimental Myocardial Infarction
Objectives
To investigate if the protective effects of xenon and isoflurane against myocardial ischemia-reperfusion damage would be additive.
Design
A prospective, randomized laboratory investigation.
Setting
An animal laboratory of a university hospital.
Participants
Thirty-six pigs (female German landrace).
Interventions
In an open-chest preparation with thiopental anesthesia, the left anterior descending artery was occluded to produce ischemia for 60 minutes. One hour previously, ischemic preconditioning, isoflurane (0.55 minimum alveolar concentration [MAC]) alone, or isoflurane together with xenon (0.55 MAC each) were started in the respective groups. A fourth (control) group received no protective intervention. Myocardial ischemia was followed by 2 hours of reperfusion.
Measurements and Main Results
Hearts were excised and stained (Evans Blue/TTC) to measure infarct size as related to the area at risk. Myocardial infarct size was reduced (means ± standard deviation) from 64% ± 9% of the area at risk in the control group to 19% ± 12% with ischemic preconditioning to 46% ± 12% with isoflurane and to 39% ± 13% with isoflurane and xenon. All intervention groups were significantly different from the control (p < 0.05), and both anesthetic groups were significantly different from ischemic preconditioning (p < 0.05).
Conclusion
Combined isoflurane/xenon anesthesia reduced infarct size but not more than isoflurane alone. Ischemic preconditioning was more effective than the anesthetics.
Key Words: myocardial preconditioning, inhalation anesthesia, xenon, isoflurane
To access this article, please choose from the options below
Supported by the Deutsche Forschungsgemeinschaft (DFG Ro 2000/6-1) and by Air Liquide Deutschland GmbH (xenon donation).
PII: S1053-0770(09)00031-7
doi:10.1053/j.jvca.2009.01.028
© 2009 Elsevier Inc. All rights reserved.
Volume 23, Issue 5 , Pages 614-618, October 2009
